X

Health Care

Earnings Preview: Will the talc debacle devour Johnson & Johnson in Q4?

Healthcare giant Johnson & Johnson (JNJ) will kick off pharma earnings for the fourth-quarter as it posts its quarterly and…

Why Ligand Pharma, Viking Therapeutics tumbled yesterday, but is gaining today

Shares of Ligand Pharmaceuticals (LGND) took a beating on Wednesday after a bearish report by Citron Research led by short-seller…

Microsoft-Walgreens deal highlights an emerging trend in healthcare sector

While the healthcare sector is witnessing a dramatic change in the way companies operate, marked by high-profile partnerships, the tech…

UnitedHealth beats estimates on Q4 results

UnitedHealth Group (UNH) surpassed market expectations on both revenue and earnings for the fourth quarter of 2018. Shares were up…

Verona Pharma stock plunges to all time low on disappointing trial

Verona Pharma plc (VRNA) stock plunged to an all-time low of $5.76 on Monday as its lead chronic inflammatory lung…

Aurora gets bigger with Whistler buyout as cannabis boom gains traction

The cannabis market seems to be on the verge of an explosion - with the majority of companies expediting their…

Earnings preview: Strong Q4 results might lift UnitedHealth Group’s stock

UnitedHealth Group (UNH) is scheduled to report fourth-quarter 2018 earnings results on Tuesday, January 15. Analysts expect the company to…

Axsome Therapeutics almost doubles on positive outcome from Alzheimer’s disease trial

Clinical stage biopharmaceutical company Axsome Therapeutics (AXSM) announces positive outcome for ADVANCE-1 trial associated with the treatment of Alzheimer's disease. Shares of…

In a massive deal, Eli Lilly acquires Loxo Oncology

Eli Lilly and Company (LLY) on Monday announced that it would acquire a small biopharmaceutical startup that develops cancer treatment,…

Flexion Therapeutics plunges after reporting preliminary Q4 financial results

Flexion Therapeutics (Nasdaq: FLXN) reported its preliminary fourth quarter earnings results after the bell today. The biopharmaceutical company's Q4 revenue is expected…

Johnson & Johnson dips on revenue decline in India

Johnson & Johnson (JNJ) shares fell 1% on Thursday after the company reported a 3% sales dip in India in…

Bristol-Myers Squibb swallows Celgene for $74-bln; Celgene stock surges

Bristol-Myers Squibb (NYSE: BMY) acquired its peer Celgene (NASDAQ: CELG) in a $74-billion cash-and-stock deal. Under the agreement terms, Celgene…

Cambrex Corp. completes acquisition of Avista Pharma solutions

Life sciences company Cambrex Corp. (CBM) Wednesday completed its previously announced acquisition of Avista Pharma Solutions, a biotech firm engaged…

Aphria rejects Green Growth Brands’ $2.1-bln buyout offer

Aphria Inc. (NYSE: APHA and TSX: APHA) turned down the acquisition proposal by Xanthic Biopharma d.b.a. Green Growth Brands (CSE:…

Thailand legalizes medical use of cannabis, opens up a new region for pot stocks

After Uruguay and Canada, Thailand has now amended its drug law to legalize marijuana for medical purposes. However, unlike the…

Budweiser-parent mulls pot-based drinks, inks JV with Tilray

The world’s largest brewery and the parent company of Budweiser, AB InBev (BUD), has given potheads more reasons to cheer…

GSK teams up with Pfizer to announce major changes to business

GlaxoSmithKline plc (GSK) and Pfizer Inc. (PFE) have decided to combine their consumer health businesses in an all-equity transaction that…

Merck strengthens animal health division with $2.4-bln Antelliq buyout

Taking a cue from the growing demand for animal care products, healthcare service providers and pharma companies are enhancing their…

Eli Lilly to collaborate with AC Immune for the treatment of Alzheimer’s disease

Eli Lilly (NYSE: LLY) partners with Switzerland-based AC Immune (Nasdaq: ACIU) to research and develop the potential treatment for Alzheimer's…

Arrowhead Pharmaceuticals reports a loss of 12 cents per share in Q4

Arrowhead Pharmaceuticals (ARWR) reported Q4 and fiscal 2018 earnings results after the bell today. For the fourth quarter ended September 30,…

Merck announces management changes

Merck (MRK) announced that Adam Schechter, President of Global Human Health (GHH) division will step down from his present role…